Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) is -60.49% lower on its value in year-to-date trading and has touched a low of $3.79 and a high of $15.70 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IRWD stock was last observed hovering at around $4.48 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $4.52, the stock is -3.70% and -17.70% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.36 million and changing 0.89% at the moment leaves the stock -47.44% off its SMA200. IRWD registered -47.50% loss for a year compared to 6-month loss of -48.93%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -5.04% gain in the last 1 month and extending the period to 3 months gives it a -20.70%, and is 3.91% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.51% over the week and 6.69% over the month.
Ironwood Pharmaceuticals Inc (IRWD) has around 267 employees, a market worth around $722.02M and $400.56M in sales. Current P/E ratio is 104.63 and Fwd P/E is 11.54. Profit margin for the company is 2.30%. Distance from 52-week low is 19.26% and -71.21% from its 52-week high. The company has generated returns on investments over the last 12 months (2.92%).
The EPS is expected to grow by 104.01% this year
329.0 institutions hold shares in Ironwood Pharmaceuticals Inc (IRWD), with institutional investors hold 111.60% of the company’s shares. The shares outstanding are 156.35M, and float is at 155.59M with Short Float at 8.74%. Institutions hold 109.71% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 22.88 million shares valued at $149.16 million. The investor’s holdings represent 14.5067 of the IRWD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 21.56 million shares valued at $140.59 million to account for 13.6737 of the shares outstanding. The other top investors are SARISSA CAPITAL MANAGEMENT LP which holds 16.39 million shares representing 10.3932 and valued at over $106.86 million, while UBS GROUP AG holds 7.1023 of the shares totaling 11.2 million with a market value of $73.03 million.
Ironwood Pharmaceuticals Inc (IRWD) Insider Activity
The most recent transaction is an insider sale by John Minardo, the company’s Chief Legal Officer. SEC filings show that John Minardo sold 9,910 shares of the company’s common stock on Aug 12 ’24 at a price of $4.27 per share for a total of $42316.0. Following the sale, the insider now owns 0.28 million shares.
Ironwood Pharmaceuticals Inc disclosed in a document filed with the SEC on Aug 12 ’24 that Silver Ronald (Principal Accounting Officer) sold a total of 3,107 shares of the company’s common stock. The trade occurred on Aug 12 ’24 and was made at $4.27 per share for $13267.0. Following the transaction, the insider now directly holds 0.16 million shares of the IRWD stock.
Still, SEC filings show that on Aug 12 ’24, John Minardo (Officer) Proposed Sale 11,726 shares at an average price of $4.05 for $47490.0. The insider now directly holds shares of Ironwood Pharmaceuticals Inc (IRWD).
